Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.78 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.78 |
| ▸ | LMNA | P02545 | 4/20 | 0.78 |
| ▸ | MAPT | P10636 | 4/20 | 0.78 |
| ▸ | GMNN | O75496 | 3/20 | 0.78 |
| ▸ | POLB | P06746 | 3/20 | 0.78 |
| ▸ | BLM | P54132 | 3/20 | 0.78 |
| ▸ | CETP | P11597 | 3/20 | 0.78 |
| ▸ | UBE2N | P61088 | 3/20 | 0.78 |
| ▸ | THPO | P40225 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 2/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.78 |
| ▸ | MTOR | P42345 | 1/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | HTT | P42858 | 1/20 | 0.78 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | GLA | P06280 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7171764 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| SCHEMBL13780782 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| Phytosphingosine SCHEMBL5490039 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| Phytosphingosine SCHEMBL13146498 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| SCHEMBL12279953 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| Phytosphingosine SCHEMBL12563454 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| Phytosphingosine SCHEMBL14415162 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| Phytosphingosine SCHEMBL14565602 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| Phytosphingosine SCHEMBL21484046 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN | |
| SCHEMBL29822750 | 1.00 | CYP2D6 (0.78) | CYP2D6SPHK1LMNAMAPTGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116535331-A | Ceramide derived from olive oil and application thereof | 上海中翊日化有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-110117355-B | Polyester resin with excellent neutral salt spray resistance for TG IC powder coating and preparation method thereof | 黄山嘉恒科技有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112201344-A | Application of salivary metabolism marker in early diagnosis of oral lichen planus | 郑州大学第一附属医院 | 2021-01-08 | — | — | CN | claimed |
| CN-110078635-A | The synthesis and its application in Cer NP preparation that dewatering mechanism promotes amide | 上海克琴科技有限公司 | 2019-08-02 | — | — | CN | claimed |
| US-20020006420-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | PHILIPPE MICHEL (FR) | 2002-01-17 | — | — | US | claimed |
| US-6184252-B1 | 2-amino-1,3-alkanediol compositions for inducing/stimulating hair growth and/or retarding hair loss | SOCIETE L'OREAL S.A. (FR) | 2001-02-06 | — | — | US | claimed |
| EP-1001739-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | L'OREAL (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999007337-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | L'OREAL (FR) | 1999-02-18 | — | — | WO | claimed |
| EP-0790053-B1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | OREAL (FR) | 1998-10-07 | — | — | EP | claimed |
| EP-0790053-A1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | L'OREAL (FR) | 1997-08-20 | — | — | EP | claimed |
| EP-4737504-A2 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| EP-4276090-B1 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND PREPARATION AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-04-29 | — | — | EP | disclosed |
| EP-4321504-B1 | PEGYLATED LIPID AND LIPOSOME MODIFIED THEREBY, AND PHARMACEUTICAL COMPOSITION COMPRISING LIPOSOME AND PREPARATION AND USE THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-02-18 | — | — | EP | disclosed |
| US-20250339483-A1 | EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON INTRANASAL ADMINISTRATION, AND USES THEREOF | AGS THERAPEUTICS SAS (FR) | 2025-11-06 | — | — | US | disclosed |
| EP-4624449-A1 | VEGETABLE OIL CERAMIDES, SYNTHESIS METHOD THEREFOR, AND USE THEREOF | Shenzhen Dikeman Biotechnology Co., Ltd. (CN) | 2025-10-01 | — | — | EP | disclosed |
| EP-0736522-B1 | Ceramide compounds, process for their preparation and their use in cosmetics or dermatology | OREAL (FR) | 1997-12-29 | — | — | EP | disclosed |
| EP-0790053-A1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | L'OREAL (FR) | 1997-08-20 | — | — | EP | disclosed |
| EP-0768299-B1 | Process for the preparation of 2-amino-1,3,4-triol-alkanes | OREAL (FR) | 1997-08-06 | — | — | EP | disclosed |
| EP-0768299-A1 | Process for the preparation of 2-amino-1,3,4-triol-alkanes | L'OREAL (FR) | 1997-04-16 | — | — | EP | disclosed |
| EP-0736522-A1 | Ceramide compounds, process for their preparation and their use in cosmetics or dermatology | L'OREAL (FR) | 1996-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339483-A1 | EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON INTRANASAL ADMINISTRATION, AND USES THEREOF | NLN, DCX, CNTN1 | CYP2D6 4280/4885SPHK1 1390/4885LMNA 861/4885 |
| US-20020006420-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | CUTA, GLA, AGER | CYP2D6 4135/4885SPHK1 2110/4885LMNA 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.